Growth Metrics

Scholar Rock Holding (SRRK) Shares Outstanding (Weighted Average) (2017 - 2026)

Scholar Rock Holding's quarterly Shares Outstanding (Weighted Average) came in at $10.6 million in Q1 2026, down 90.56% year-on-year from $111.8 million in Q1 2025, and down 90.8% quarter-over-quarter from $114.7 million in Q4 2025.

Scholar Rock Holding has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $10.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 90.56% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (down 90.56% YoY), and the FY2025 full-year result was $114.7 million, up 14.89% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $10.6 million, down from $114.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $114.7 million in Q4 2025, with the low at $2.2 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $54.1 million, with a median of $27.7 million recorded in 2022.
  • Year-over-year, Shares Outstanding (Weighted Average) surged 3540.13% in 2022 and sank 90.56% in 2026.
  • Tracing SRRK's Shares Outstanding (Weighted Average) over 5 years: stood at $59.6 million in 2022, then soared by 39.82% to $83.3 million in 2023, then climbed by 19.79% to $99.8 million in 2024, then climbed by 14.89% to $114.7 million in 2025, then sank by 90.8% to $10.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $10.6 million (Q1 2026), $114.7 million (Q4 2025), and $17.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 177,333.76 Bn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 185,491.37 Bn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 55.66 Bn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 132.89 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 10.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.56 Mn
Dec 31, 2025 114.70 Mn
Sep 30, 2025 17.36 Mn
Jun 30, 2025 112.27 Mn
Mar 31, 2025 111.84 Mn
Dec 31, 2024 99.84 Mn
Sep 30, 2024 97.05 Mn
Jun 30, 2024 17.01 Mn
Mar 31, 2024 9.16 Mn
Dec 31, 2023 83.35 Mn
Sep 30, 2023 24.37 Mn
Jun 30, 2023 25.40 Mn
Mar 31, 2023 27.69 Mn
Dec 31, 2022 59.61 Mn
Sep 30, 2022 79.34 Mn
Jun 30, 2022 27.69 Mn
Mar 31, 2022 2.18 Mn
Dec 31, 2021 36.71 Mn
Sep 30, 2021 2.18 Mn
Jun 30, 2021 2.18 Mn
Mar 31, 2021 2.18 Mn
Dec 31, 2020 30.73 Mn
Sep 30, 2020 29.67 Mn
Jun 30, 2020 29.69 Mn
Mar 31, 2020 29.53 Mn
Dec 31, 2019 27.54 Mn
Sep 30, 2019 29.23 Mn
Jun 30, 2019 25.76 Mn
Mar 31, 2019 25.59 Mn
Dec 31, 2018 15.66 Mn
Sep 30, 2018 24.31 Mn
Jun 30, 2018 6.72 Mn
Mar 31, 2018 2.80 Mn
Dec 31, 2017 1.63 Mn
Sep 30, 2017 1.60 Mn
Jun 30, 2017 1.60 Mn